Making Dollars And Sense Out Of Copay Assistance
Executive Summary
The number of prescriptions associated with the use of copay assistance is expected to grow by 15% per year over the next decade, but there is little agreement between pharmaceutical manufacturers and payors about the benefits and drawbacks of copay-assistance programs. Analyzing the copay assistance on a case-by-case-basis will help pharma and payors find common ground by revealing the actual impact and costs associated with each program.